BIRC5 and nasopharyngeal carcinoma: For example, miR-218 can suppress nasopharyngeal cancer progression through down-regulation of BIRC5 (survivin) and the SLIT2 (slit guidance ligand 2)-ROBO1 (roundabout guidance receptor 1) pathway22.